• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒之谜:成人多系统炎症综合征(MIS-A)是否可预测?

Enigma of COVID-19: is "multisystem inflammatory syndrome in adults" (MIS-A) predictable?

机构信息

Department of Hematology, Istanbul Training and Research Hospital, University of Health Sciences, Org.Nafiz GURMAN Cad. Fatih, 34098, Istanbul, Turkey.

Department of Clinical Microbiology and Infectious Diseases, Istanbul Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.

出版信息

BMC Infect Dis. 2022 Mar 28;22(1):300. doi: 10.1186/s12879-022-07303-8.

DOI:10.1186/s12879-022-07303-8
PMID:35346086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8960085/
Abstract

BACKGROUND

Severe inflammation and one or more extrapulmonary organ dysfunctions have been reported and this clinical picture is defined as "multisystem inflammatory syndrome in adults" (MIS-A) in severe coronavirus disease-2019 (COVID-19). We aimed to determine the effect of LDH/lymphocyte ratio (LLR) on the development of MIS-A.

METHODS

The data of 2333 patients were retrospectively analyzed.

RESULTS

MIS-A rate was found to be 9.9% and MIS-A related mortality was 35.3%. LRR level above 0.24 was found to predict MIS-A development with 70% sensitivity and 65.2% specificity. The risk of MIS-A development was found to be 3.64 times higher in those with LRR levels above 0.24 compared to those with 0.24 and below. In patients with MIS-A, LRR level above 0.32 predicts mortality with 78% sensitivity and 70% specificity.

CONCLUSIONS

Early detection of MIS-A with high sensitivity and specificity in a practical ratio is very important in terms new studies.

摘要

背景

据报道,严重的炎症和一个或多个肺外器官功能障碍已经出现,这种临床表现在严重的 2019 冠状病毒病(COVID-19)中被定义为“成人多系统炎症综合征”(MIS-A)。我们旨在确定乳酸脱氢酶/淋巴细胞比值(LLR)对 MIS-A 发展的影响。

方法

回顾性分析了 2333 例患者的数据。

结果

MIS-A 发生率为 9.9%,MIS-A 相关死亡率为 35.3%。发现 LRR 水平高于 0.24 可预测 MIS-A 发生,其敏感性为 70%,特异性为 65.2%。与 LRR 水平低于 0.24 的患者相比,LRR 水平高于 0.24 的患者发生 MIS-A 的风险高 3.64 倍。在 MIS-A 患者中,LRR 水平高于 0.32 预测死亡率,其敏感性为 78%,特异性为 70%。

结论

在新的研究中,用实用比值以高敏感性和特异性早期检测 MIS-A 非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be6/8962063/0ae46de3d274/12879_2022_7303_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be6/8962063/7ebe8e9f812c/12879_2022_7303_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be6/8962063/0ae46de3d274/12879_2022_7303_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be6/8962063/7ebe8e9f812c/12879_2022_7303_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be6/8962063/0ae46de3d274/12879_2022_7303_Fig2_HTML.jpg

相似文献

1
Enigma of COVID-19: is "multisystem inflammatory syndrome in adults" (MIS-A) predictable?新冠病毒之谜:成人多系统炎症综合征(MIS-A)是否可预测?
BMC Infect Dis. 2022 Mar 28;22(1):300. doi: 10.1186/s12879-022-07303-8.
2
Multisystem inflammatory syndrome in adults with COVID-19 requiring mechanical ventilation: A retrospective cohort study.新型冠状病毒肺炎成年患者多系统炎症综合征需机械通气治疗:一项回顾性队列研究。
Acute Med Surg. 2023 Aug 25;10(1):e885. doi: 10.1002/ams2.885. eCollection 2023 Jan-Dec.
3
Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children.比较并发于全身型幼年特发性关节炎和儿童多系统炎症综合征的巨噬细胞活化综合征的基线实验室检查结果。
Int J Rheum Dis. 2021 Apr;24(4):542-547. doi: 10.1111/1756-185X.14078. Epub 2021 Feb 7.
4
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.儿童多系统炎症综合征(MIS-C)与 COVID-19 相关:土耳其南部一家三级保健医院的病例系列经验。
J Trop Pediatr. 2021 May 17;67(2). doi: 10.1093/tropej/fmab050.
5
Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean.土耳其 COVID-19 大流行期间儿童多系统炎症综合征:来自东地中海地区的首次报告。
Clin Rheumatol. 2021 Aug;40(8):3227-3237. doi: 10.1007/s10067-021-05631-9. Epub 2021 Feb 12.
6
A COVID-19 mystery: multisystem inflammatory syndrome in adults (MIS-A) associated with splenic rupture.
New Microbiol. 2023 Feb;46(1):81-85.
7
Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19.社论:成人多系统炎症综合征(MIS-A)与 COVID-19 谱。
Med Sci Monit. 2021 Oct 11;27:e935005. doi: 10.12659/MSM.935005.
8
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.儿童和青少年中严重的 SARS-CoV-2 表现:从 COVID-19 肺炎到多系统炎症综合征:西班牙儿科重症监护病房的一项多中心研究。
Crit Care. 2020 Nov 26;24(1):666. doi: 10.1186/s13054-020-03332-4.
9
Multisystem inflammatory syndrome (MIS): a multicentre retrospective review of adults and adolescents in South Africa.多系统炎症综合征(MIS):南非成人及青少年的多中心回顾性研究
Int J Infect Dis. 2021 Oct;111:227-232. doi: 10.1016/j.ijid.2021.08.042. Epub 2021 Aug 21.
10
Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19.儿童多系统炎症综合征(MIS-C)与儿童 COVID-19 的胸部 X 线特征比较。
Pediatr Radiol. 2021 Feb;51(2):231-238. doi: 10.1007/s00247-020-04921-9. Epub 2021 Jan 6.

引用本文的文献

1
Esophageal ulcer and multisystem inflammatory syndrome after COVID-19: A case report.新型冠状病毒肺炎后食管溃疡与多系统炎症综合征:一例报告
World J Gastrointest Endosc. 2024 Aug 16;16(8):483-488. doi: 10.4253/wjge.v16.i8.483.
2
Fatal multisystem inflammatory syndrome in a 78-year-old adult after severe COVID-19 pneumonia during 2022 Omicron variant epidemic in Shanghai, China.2022 年中国上海奥密克戎变异株流行期间,一名 78 岁成年人在严重 COVID-19 肺炎后发生致命的多系统炎症综合征。
J Infect Public Health. 2023 Mar;16(3):418-421. doi: 10.1016/j.jiph.2023.01.003. Epub 2023 Jan 11.
3
A Case of Multisystem Inflammatory Syndrome in an Immunosuppressed Adult.

本文引用的文献

1
COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?新型冠状病毒肺炎与细胞因子风暴综合征:巨噬细胞活化综合征能带来哪些启示?
Transl Res. 2021 Jun;232:1-12. doi: 10.1016/j.trsl.2021.03.002. Epub 2021 Mar 5.
2
Haemophagocytic syndrome and COVID-19.噬血细胞综合征与 COVID-19。
Clin Rheumatol. 2021 Apr;40(4):1233-1244. doi: 10.1007/s10067-020-05569-4. Epub 2021 Jan 3.
3
A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality.
一名免疫抑制成人的多系统炎症综合征病例。
Cureus. 2022 Jun 3;14(6):e25635. doi: 10.7759/cureus.25635. eCollection 2022 Jun.
COVID-19 大流行中的一个新参数:初始乳酸脱氢酶(LDH)/淋巴细胞比值用于诊断和死亡率预测。
J Infect Public Health. 2020 Nov;13(11):1664-1670. doi: 10.1016/j.jiph.2020.09.009. Epub 2020 Sep 30.
4
Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020.2020 年 3 月至 8 月,英国和美国出现与 SARS-CoV-2 感染相关的成人多系统炎症综合征病例系列。
MMWR Morb Mortal Wkly Rep. 2020 Oct 9;69(40):1450-1456. doi: 10.15585/mmwr.mm6940e1.
5
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.新型冠状病毒肺炎相关过度炎症综合征的临床标准:一项队列研究
Lancet Rheumatol. 2020 Dec;2(12):e754-e763. doi: 10.1016/S2665-9913(20)30343-X. Epub 2020 Sep 29.
6
Preliminary predictive criteria for COVID-19 cytokine storm.COVID-19 细胞因子风暴的初步预测标准。
Ann Rheum Dis. 2021 Jan;80(1):88-95. doi: 10.1136/annrheumdis-2020-218323. Epub 2020 Sep 25.
7
Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.严重 COVID-19 患者中的继发性噬血细胞性淋巴组织细胞增生症与细胞因子释放综合征。
Exp Biol Med (Maywood). 2021 Jan;246(1):5-9. doi: 10.1177/1535370220962043. Epub 2020 Sep 24.
8
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.新型冠状病毒肺炎肺血管内凝血病变的免疫机制
Lancet Rheumatol. 2020 Jul;2(7):e437-e445. doi: 10.1016/S2665-9913(20)30121-1. Epub 2020 May 7.
9
The cytokine storm of COVID-19: a spotlight on prevention and protection.新型冠状病毒引发的细胞因子风暴:聚焦预防与保护。
Expert Opin Ther Targets. 2020 Aug;24(8):723-730. doi: 10.1080/14728222.2020.1783243. Epub 2020 Jun 27.
10
Coronavirus Disease 2019-COVID-19.新型冠状病毒肺炎。
Clin Microbiol Rev. 2020 Jun 24;33(4). doi: 10.1128/CMR.00028-20. Print 2020 Sep 16.